Dutasteride reduces alcohol’s sedative effects in men in a human laboratory setting and reduces drinking in the natural environment
February 2014
in “Psychopharmacology”
TLDR Dutasteride makes alcohol less sedating and may lead to less drinking in men.
The study, involving 70 men, examined the impact of dutasteride, a drug that inhibits 5α-reduced neuroactive steroids, on alcohol's sedative effects and drinking behavior. Participants received either 4 mg of dutasteride or a placebo before consuming alcohol or a placebo beverage. Results showed that dutasteride significantly reduced the sedative effects of alcohol, with no interaction with the GABRA2 polymorphism. Heavy drinkers experienced fewer heavy drinking days and total drinks following dutasteride treatment. The study concluded that dutasteride may reduce alcohol consumption by affecting neuroactive steroid concentrations, with no significant adverse effects reported.
View this study on link.springer.com →
Cited in this study
research Decreased Alcohol Consumption Among Former Male Users of Finasteride with Persistent Sexual Side Effects: A Preliminary Report
Finasteride use may lead to less alcohol consumption in men with lasting sexual side effects.
research Alteration of Ethanol Drinking in Mice via Modulation of the GABAA Receptor with Ganaxolone, Finasteride, and Gaboxadol
Three drugs change mice's alcohol drinking patterns by affecting GABAA receptors.
research Treatment with and withdrawal from finasteride alter ethanol intake patterns in male C57BL/6J mice: Potential role of endogenous neurosteroids?
Finasteride affects alcohol intake in male mice, possibly due to neurosteroids.
research GABRA2 Alleles Moderate the Subjective Effects of Alcohol, Which are Attenuated by Finasteride
GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.
research Comparison of finasteride versus flutamide in the treatment of hirsutism
Finasteride is a safe, effective treatment for hirsutism with fewer side effects.
research A model for the turnover of dihydrotestosterone in the presence of the irreversible 5α-reductase inhibitors GI198745 and finasteride
Both drugs lower DHT levels, with GI198745 being more effective.
research 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.
research Effects of Finasteride (MK-906), a 5α-Reductase Inhibitor, on Circulating Androgens in Male Volunteers*
Finasteride safely lowers DHT levels without affecting testosterone.